Product NDC: | 55289-319 |
Proprietary Name: | Ranitidine |
Non Proprietary Name: | Ranitidine |
Active Ingredient(s): | 150 mg/1 & nbsp; Ranitidine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55289-319 |
Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077824 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091216 |
Package NDC: | 55289-319-20 |
Package Description: | 20 TABLET in 1 BOTTLE, PLASTIC (55289-319-20) |
NDC Code | 55289-319-20 |
Proprietary Name | Ranitidine |
Package Description | 20 TABLET in 1 BOTTLE, PLASTIC (55289-319-20) |
Product NDC | 55289-319 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ranitidine |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20091216 |
Marketing Category Name | ANDA |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Substance Name | RANITIDINE HYDROCHLORIDE |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |